Animal health companies rarely struggle because nobody cares about animals. They struggle because caring is not the same as buying.
A veterinarian may believe in the clinical value of a new product while a practice manager worries about implementation, a practice owner questions the return on investment, corporate procurement examines security and pricing, and an animal owner decides whether the recommendation is affordable. In livestock health, the buyer may also need to consider herd productivity, food safety, labor, distribution and regulatory requirements.
That is what makes animal health marketing unusually complex. It sits at the intersection of healthcare, life sciences, technology, agriculture and consumer behavior. The category includes pharmaceuticals, veterinary biologics, diagnostics, medical imaging, laboratory services, practice management software, AI tools, nutrition, insurance, telehealth, medical devices and products for companion animals, equine care, livestock and other species.
The foundational animal health marketing activities should happen in this order:
The order matters. A veterinary B2B company that buys ads or sponsors a major conference before completing the first seven steps may generate attention, but its team will have a much harder time converting that attention into qualified opportunities.
Animal health marketing is the strategy & execution used to build awareness, credibility, adoption and demand for products or services that improve animal care, veterinary operations or the broader animal health ecosystem.
It can include:
The Centers for Disease Control and Prevention describes One Health as an approach that recognizes the connection between the health of people, animals and the shared environment. That connection creates important opportunities for animal health companies, but it also means their communications may need to reach clinical, scientific, agricultural, public health and consumer audiences. Learn more about One Health from the CDC.
Animal health is not one market
“Veterinarians” is not a sufficiently specific target audience.
A companion animal general practitioner, veterinary radiologist, equine veterinarian, dairy production veterinarian, shelter medicine leader and laboratory animal veterinarian have different clinical needs, business models, terminology, workflows and sources of information. The same is true of independent clinics, specialty hospitals, university veterinary centers and corporate veterinary groups.
Consider a medical imaging company looking to reach veterinarians. Its actual priority audience might be:
The company may eventually market to all of them, but it should not use one message for all of them.
In animal health, the veterinarian may recommend a product without purchasing it. A technician may use a platform without selecting it. A practice manager may lead the evaluation while the owner signs the contract. The animal receives the clinical benefit, but a pet owner, producer or institution often pays.
For example, a veterinary-specific health tech SaaS practice management platform might want to reach practice managers. That is a reasonable starting point, but the complete buying committee could include:
Practice Manager: workflow, staffing, training and implementation
Veterinarian or Medical Director: clinical usability and quality of care
Practice Owner: financial impact and business continuity
Corporate IT Team: integrations, security and data migration
Front Desk Team: scheduling, payments and client communication
Veterinary Technicians: documentation and daily workflow
Marketing only to the practice owner would miss the people most likely to champion or block adoption.
Animal health marketing teams cannot apply one compliance process across every product category.
The FDA Center for Veterinary Medicine regulates animal drugs, animal food and feed and animal medical devices. Prescription animal drug promotion cannot be false or misleading, and FDA can issue regulatory letters when materials violate applicable law. Review FDA guidance on prescription animal drug promotion.
Veterinary biologics, including vaccines, bacterins, antisera and certain diagnostic kits, are regulated by the USDA Animal and Plant Health Inspection Service. These products must meet applicable standards for purity, safety, potency and effectiveness. Learn about USDA oversight of veterinary biologics.
Some flea and tick products are regulated as pesticides by the EPA, while other animal health products fall under FDA oversight. Review EPA guidance on flea and tick product regulation.
This means a claim that is appropriate for a veterinary workflow platform may be unacceptable for an animal drug. Even within the same campaign, scientific exchange, investor communications, disease awareness and product promotion may require different reviews.
Veterinary teams are being asked to evaluate new technologies while managing staffing pressure, changing client expectations and tighter economics. AVMA reported that veterinary practice visits declined by roughly 3% nationally in 2025 while revenue rose about 2.5%, reflecting continued price sensitivity and pressure on practice growth. Read the AVMA analysis.
That environment changes the marketing message. "Innovative” is not enough. Veterinary B2B marketing must explain:
Healthcare technology often fails to gain adoption when it adds work to an already burdened team. Animal health technology is no exception.
An AI imaging company may lead with model performance, but a veterinary hospital may be more concerned about whether the solution integrates with its imaging system, how cases enter the worklist, when a veterinarian sees the output, what happens when the model is uncertain and whether technicians need additional training.
A veterinary practice management platform may promote dozens of features, while the practice manager primarily wants to know:
The strongest animal health marketing connects the product to the real workflow.
Animal health is a relationship-driven field. Veterinarians consult peers, specialists, professional associations, distributors, scientific literature, continuing education, conferences and trusted trade media. In narrow specialties, a small number of respected experts may influence an entire category.
That creates an advantage for credible companies and a challenge for unknown ones. A strong veterinary B2B marketing strategy needs to earn trust through evidence, expert voices and repeated visibility. It cannot depend on paid reach alone.
Before choosing channels, decide exactly where the company intends to win.
A useful initial market definition should include:
“Reach more veterinarians” is not a commercial objective. “Generate qualified demonstrations with practice managers at independently owned, multi-doctor companion animal hospitals that are replacing a legacy practice management system” is.
Examples:
The output of this step should be a prioritized ideal customer profile, a clear commercial goal and a list of segments that are deliberately out of scope for the initial program.
Next, identify every person who can create, influence, approve, delay or block the purchase.
|
Animal health offering |
Likely champion or user |
Economic buyer |
Important influencers or blockers |
|
Veterinary imaging equipment |
Veterinary radiologist, surgeon or technician |
Practice owner or corporate operations leader |
Finance, facilities, IT, procurement and service team |
|
Veterinary practice management SaaS |
Practice manager |
Practice owner or corporate executive |
Veterinarians, technicians, front desk, IT and finance |
|
Animal health diagnostic test |
Specialist veterinarian or laboratory director |
Hospital, laboratory or purchasing leader |
Pathologists, technicians, distributors and regulatory teams |
|
Veterinary pharmaceutical |
Veterinarian |
Practice, distributor, producer or animal owner |
Technicians, pharmacists, key opinion leaders and regulatory reviewers |
|
Livestock monitoring platform |
Herd manager or production veterinarian |
Producer or agricultural enterprise |
Farm labor, nutritionists, IT and financial advisors |
|
Animal health CDMO services |
Scientific, CMC or product development leader |
Biotech or pharmaceutical executive |
Quality, regulatory, procurement and investors |
For each role, document:
This prevents a common mistake in animal health marketing: asking one page, one deck or one sales representative to explain everything to everyone.
Do not build positioning from internal assumptions alone. Interview customers, lost prospects, industry experts, sales teams, implementation staff and channel partners.
Ask questions that reveal decisions, not compliments:
For a veterinary practice management platform, research might reveal that “more efficient operations” is too abstract. Practice managers may repeatedly describe staying late to reconcile payments, rebuilding schedules after cancellations or training new staff across disconnected systems. Those phrases should influence the messaging and content.
For an imaging company, interviews may show that veterinarians are satisfied with image quality but frustrated by service delays, equipment downtime or inconsistent protocols across locations. The strongest differentiator may be support and standardization rather than a technical specification the company originally planned to lead with.
Competitive research should examine more than websites. Review:
The goal is to find a position the market values, the company can prove and competitors do not already own.
Positioning should explain:
Weak animal health technology positioning:
> We are revolutionizing veterinary care through an innovative AI-powered platform.
Stronger positioning for a defined imaging audience:
> Our veterinary imaging platform helps specialty and emergency hospitals prioritize time-sensitive radiographs, standardize review workflows and give clinical teams decision support when every minute matters.
Weak veterinary SaaS positioning:
> An all-in-one solution that transforms your veterinary practice.
Stronger positioning for practice managers:
> A veterinary practice management platform built to reduce scheduling, payment and communication work across busy multi-doctor practices, with guided migration and role-based training that helps teams adopt it faster.
Weak animal health CDMO positioning:
> Your trusted partner from concept to commercialization.
Stronger positioning:
> Development and manufacturing support for emerging animal health companies advancing sterile therapeutics, with veterinary formulation experience, scalable processes and regulatory documentation designed for efficient technology transfer.
The messaging architecture should include a core narrative, audience-specific value propositions, approved proof points, objection responses and a claims matrix showing which statements can be used in which contexts.
Animal health buyers need different forms of proof at different stages.
Clinical proof may include:
Operational proof may include:
Commercial proof may include:
For example:
Do not inflate a pilot result into a universal claim. Build a proof library that links every important message to an approved source.
The website should help each priority audience quickly determine:
A strong animal health website may need dedicated pages by audience, use case, species, care setting or product line.
Examples:
Each page should have one clear purpose and conversion path. A veterinary radiologist may want technical documentation. A practice manager may want an implementation guide. A corporate buyer may want a demonstration. A scientific partner may want to discuss development feasibility.
Generative engine optimization, or GEO, improves the ability of generative search and answer platforms to find, understand, summarize and potentially cite a company’s information.
For animal health companies, GEO starts with the same fundamentals that support strong SEO:
Google’s official guidance says the foundations of SEO remain relevant to generative AI search. It emphasizes unique, useful content, clear technical structure and crawlability rather than GEO "hacks.” Review Google’s guidance for generative AI search.
The best GEO content often comes directly from sales, support and conference conversations.
If practice managers repeatedly ask, "How long does it take to migrate veterinary practice software?” create a page that answers the question directly, explains the variables and shows the process.
If veterinary radiologists ask, "Can AI-generated imaging output be added to our current worklist?” create an integration page with a workflow diagram, supported systems and technical review process.
If an animal health biotech hears, "What is different about developing a long-acting injectable for companion animals?” commission an expert article that explains formulation, dosing, species and manufacturing considerations without drifting into unsupported claims.
Marketing should equip the sales team before it increases lead volume.
Foundational veterinary B2B sales materials may include:
A practice manager considering veterinary SaaS needs a migration timeline, training plan and implementation checklist. A veterinarian needs to see how the platform supports care without disrupting workflow. Corporate IT needs security, architecture and integration information.
An imaging company may need one clinical document for veterinarians and a separate business case for the owner or finance team. Sending both audiences the same technical brochure forces each buyer to find the information that matters to them.
Once the positioning, proof, website and sales foundation are ready, the company can scale visibility.
Useful content pillars include:
Examples:
Animal health PR should not be limited to product announcements. A stronger healthcare PR program can include:
The goal is repeated credibility with the buyers, partners, journalists and experts who shape the category.
Paid media, account-based marketing, email nurture and conferences work better after the message and conversion infrastructure are ready.
The channel mix should match the audience.
A veterinary practice management SaaS company might use:
A veterinary imaging company might prioritize:
An animal health life sciences company might use:
Conference marketing should include three stages:
The booth is not the strategy. It is one touchpoint inside the strategy.
Animal health marketing measurement should connect visibility to commercial progress.
Track metrics by stage:
Awareness:
Consideration:
Commercial Progress:
Adoption & Advocacy:
Raw lead volume can be misleading in a specialized veterinary B2B market. Ten qualified conversations with the right hospital groups may be more valuable than 1,000 general pet-owner downloads.
Segment by species, specialty, setting, ownership model, workflow and buying role.
Veterinary buyers do not need another "revolutionary platform.” They need a credible solution to a clinical, operational or commercial problem.
Emotion matters, but a practice manager, specialist or procurement leader also needs evidence, workflow and economic value.
More traffic will not fix unclear positioning, thin evidence or a weak conversion path.
Regulatory and medical review should influence the claims architecture, content plan and campaign design from the beginning.
If adoption requires migration, training, integration or workflow change, implementation is part of the product story.
Broad summaries add little value. Answer the specific questions veterinary buyers ask and add expertise, evidence, examples and a distinct point of view.
Without pre-event targeting and post-event follow-up, even an impressive booth can become an expensive three-day awareness exercise.
Pet marketing generally focuses on animal owners as consumers. Animal health marketing may target veterinarians, practice managers, hospitals, laboratories, producers, distributors, researchers, pharmaceutical companies and other professional buyers. Many animal health companies need both B2B and B2C strategies, but the audiences, evidence and conversion paths should remain distinct.
Veterinary B2B marketing promotes products or services sold to veterinary organizations or professionals rather than directly to pet owners. Examples include practice management software, diagnostic platforms, laboratory services, imaging equipment, pharmaceuticals, biologics, medical devices, staffing solutions and consulting.
Most animal health companies should first establish positioning, proof, a credible website and sales enablement. PR is often the next strong investment because it builds the third-party credibility specialized healthcare and life sciences buyers need. Paid media becomes more efficient once the message, audience and conversion path have been validated.
The strongest content answers a specific clinical, operational, scientific or commercial question. High-value formats include evidence explainers, implementation guides, comparison pages, expert QandA articles, original research, customer stories, workflow diagrams, conference insights and regulatory commentary.
Publish original expert content, answer questions directly, identify products and audiences clearly, support claims with credible sources, maintain crawlable technical pages and build a connected body of useful information around the questions buyers actually ask. GEO should strengthen good SEO and content strategy rather than replace them.
Conference planning should begin after the company has a defined audience, clear message, credible proof, useful sales materials and a follow-up system. Sponsorship alone does not create a conference strategy.
Animal health marketing is specialized healthcare marketing. It demands scientific credibility, regulatory awareness, workflow fluency and a precise understanding of how veterinary organizations make decisions.
The companies that grow efficiently do not begin with channels. They begin with the market, the buyer and the proof. Then they build the positioning, website, sales enablement, content, animal health PR and demand generation needed to turn a promising innovation into a credible commercial choice.
Sōvyn helps animal health, veterinary technology, healthcare and life sciences companies clarify their position, build authority and create integrated PR and marketing programs that move specialized B2B buyers from awareness to action.